📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. (2022)

First Author: Mahil SK

Attributed to: Optimising therapeutic strategy in psoriasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(21)00333-7

PubMed Identifier: 34778846

Publication URI: http://europepmc.org/abstract/MED/34778846

Type: Journal Article/Review

Volume: 4

Parent Publication: The Lancet. Rheumatology

Issue: 1

ISSN: 2665-9913